Intrinsic Value

Not Available for MDXXF

There is not enough data to reliably calculate the intrinsic value for Pharmala Biotech Holdings Inc.

Do our valuations actually work? See backtest results .

Alternatives to MDXXF

Fundamental Analysis

What Pharmala Biotech Does

PharmAla Biotech Holdings is a Canadian drug-development company focused on MDMA and related psychedelic compounds. It does not sell a consumer medicine business; instead, it works in the regulated supply chain for research and future medical use. The company’s core job is to make these substances under controlled standards and help move them through the approvals process.

Headquarters
Canada CA
IPO date
Jan 11, 2022
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pharmala Biotech Holdings Inc

Wall St Price Targets

Capital Returns

Competitive Landscape